Combat veterans with persistent back pain after fusion sometimes face a recommendation for re-fusion at adjacent levels. Biologic disc repair via intra-annular fibrin injection offers an alternative when imaging shows annular tears at adjacent levels as the current pain driver. The procedure preserves remaining motion and avoids extending the fused segment.
Key Takeaways
- Adjacent-segment degeneration after fusion is a recognized long-term complication.
- Re-fusion at adjacent levels is one option but extends motion loss.
- Biologic disc repair targets adjacent annular tears without further fusion.
- 80% of patients with prior failed surgery reported positive outcomes in published cohorts.
- Imaging plus history determines which path fits.
What This Guide Covers
- Why does re-fusion come up?
- What does biologic repair offer instead?
- How does a veteran decide?
- How does access work for veterans?
Why does re-fusion come up?
Re-fusion comes up when adjacent-segment degeneration produces pain at the levels above or below an existing fusion. Surgical thinking commonly extends the fusion to include the new symptomatic level. The trade-off: more permanent motion loss and a longer recovery, with FBSS rates that compound across surgeries.
What does biologic repair offer instead?
Biologic disc repair offers a non-surgical path to address adjacent-level annular tears directly. The fibrin procedure delivers an FDA-approved fibrin sealant into the tear under fluoroscopic guidance. The remaining motion in the spine is preserved. The fusion itself is not revised or extended.
How does a veteran decide?
Decision-making rests on imaging review, history, and goals. The Valor team identifies whether the adjacent-level lesion is a fibrin candidate or whether the structural picture truly requires surgical extension. Patients with surgical-fit anatomy are referred toward surgery; patients with procedure-fit anatomy have the procedure on the table.
How does access work for veterans?
Mission Act community-care is the typical access pathway. The VA primary care or specialty provider submits the consult; Valor prepares the supporting clinical documentation. Approval timelines run two to six weeks for non-emergent specialty referrals.
Clinical Note
Combat veterans facing re-fusion are some of the patients we work hardest to help. Many have already given up significant motion to the original fusion. Adding more is a real cost that is sometimes necessary and sometimes not. Our clinical staff reads the imaging carefully, talks the veteran through the trade-offs, and recommends what the anatomy supports — including surgery when surgery is the right answer. The Valor team treats these decisions with the seriousness they deserve. The veteran has earned a careful evaluation, not a quick recommendation.
Frequently Asked Questions
Is biologic repair a substitute for re-fusion in every case?
No. Some adjacent-level cases truly require surgical extension. Imaging plus history determines which fits.
Will my service-connection rating change with treatment?
No. Treatment is a delivery question, not a rating action.
How long is recovery compared to re-fusion?
Fibrin procedure recovery runs weeks; re-fusion recovery runs months.
This content is for general informational purposes only and does not constitute medical advice, diagnosis, or treatment. It is not a substitute for evaluation by a qualified physician. Treatment decisions depend on your individual medical history and clinical findings. Schedule a consultation to discuss whether the procedure is right for you.
